Please assess the completion status of the following clinical trial:

Trial Title: Neuropsychological Effects of Hydrocortisone in Patients With Partial Adrenal Insufficiency

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adult patients (male and female) between 18 and 75 years~* 1 -12 month after TBI or SAH before prescreening~* Cortisol level 100-180 ng/ml after stimulation with ACTH~* Written informed consent by patient or a legally accepted representative~Exclusion Criteria:~* Pregnancy and lactation period (during study treatment)~* Concomitant or previous high-dose therapy with glucocorticoids; previous treatment with glucocorticoids will be accepted, if it has been low dose (i.e. lower than the Cushing threshold) and has been stopped at least 3 months before study participation~* Suspected or known hypersensitivity to hydrocortisone or any of its components~* Albumine less than 2,5 g/dl~* Suspected or known drug or alcohol abuse~* Planned treatment for thyroid dysfunction or a planned change in established thyroid treatment~* Any condition which in the opinion of the investigator makes the patient unsuitable for inclusion.~* Participation in another clinical trial with investigational new drugs~* Severe medical or psychiatric disease~* Change of dosage of any other drug which might influence the corticotrope axis or cognitive function (e.g. antidepressive treatment) during the last 3 weeks~* Oral contraceptives~* Severe disturbances in articulation, visual faculty or hearing~* Any elective surgery or medical treatment planned in the observation period~* Intensive Care treatment

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- placebo/20 mg hydrocortisone (Type: PLACEBO_COMPARATOR): Order of study treatment: 7 days placebo followed by 7 days 20 mg hydrocortisone
- 20 mg hydrocortisone/placebo (Type: ACTIVE_COMPARATOR): Order of study treatment: 7 days 20 mg hydrocortisone followed by 7 days placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).